- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Rifaximin – November 2012
Rifaximin, tablet, 550 mg, Xifaxan®
Last updated
8 November 2023